Vireo Growth (VREOF) Income from Continuing Operations (2020 - 2026)

Vireo Growth's (VREOF) quarterly Income from Continuing Operations came in at 22500000.0 in Q1 2026, down 246.15% year-on-year from 15394736.84 in Q1 2025, and up 33.39% quarter-over-quarter from 33778228.0 in Q4 2025.

Vireo Growth (VREOF) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Income from Continuing Operations across 7 years of filings, most recently posting 22500000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 22500000.0, down 246.15% year-over-year; the trailing twelve-month figure through Mar 2026 was 97511118.0 (down 250.81% YoY), and the FY2025 annual result was 81519908.0, down 191.06% from the prior year.
  • Income from Continuing Operations came in at 22500000.0 for Q1 2026 at Vireo Growth, up from 33778228.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 3838163.0 in Q4 2023 to a low of 33778228.0 in Q4 2025.
  • The 5-year median for Income from Continuing Operations is 7389255.0 (2023), against an average of 10968656.53.
  • Across the five-year window, Income from Continuing Operations soared 214.89% in 2023 and tumbled 2134.26% in 2025, its largest moves.
  • Vireo Growth's Income from Continuing Operations stood at 3340798.0 in 2022, then jumped by 214.89% to 3838163.0 in 2023, then slumped by 509.08% to 15701281.0 in 2024, then sank by 115.13% to 33778228.0 in 2025, then jumped by 33.39% to 22500000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 22500000.0 (Q1 2026), 33778228.0 (Q4 2025), and 26298861.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Vireo Growth - - 59.30 Mn -22.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -22.50 Mn
Dec 31, 2025 -33.78 Mn
Sep 30, 2025 -26.30 Mn
Jun 30, 2025 -14.93 Mn
Mar 31, 2025 -6.50 Mn
Dec 31, 2024 -15.70 Mn
Sep 30, 2024 -4.93 Mn
Jun 30, 2024 -668,411.00
Mar 31, 2024 -6.71 Mn
Dec 31, 2023 3.84 Mn
Sep 30, 2023 -5.73 Mn
Jun 30, 2023 -7.39 Mn
Mar 31, 2023 -8.47 Mn
Dec 31, 2022 -3.34 Mn
Sep 30, 2022 -9.57 Mn
Jun 30, 2022 -6.10 Mn
Mar 31, 2022 -17.68 Mn
Dec 31, 2021 -14.09 Mn
Sep 30, 2021 -6.84 Mn
Jun 30, 2021 -6.99 Mn